{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:35:39Z","timestamp":1792002939940,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.diagmicrobio.2015.01.001","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T05:19:10Z","timestamp":1420780750000},"page":"269-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Flomoxef showed excellent in vitro activity against clinically important gram-positive and gram-negative pathogens causing community- and hospital-associated infections"],"prefix":"10.1016","volume":"81","author":[{"given":"Qiwen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/sur.2008.0020","article-title":"In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"10","author":"Baquero","year":"2009","journal-title":"Surg Infect"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0010","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/AAC.46.3.630-637.2002","article-title":"Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China","volume":"46","author":"Chanawong","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0015","series-title":"Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0020","series-title":"Twenty-fourth informational supplement","article-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2014"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0025","first-page":"757","article-title":"Influence of Mueller-Hinton broth on the in vitro activities of cefuzoname, flomoxef, imipenem, and minocycline against Staphylococcus aureus","volume":"43","author":"Fujita","year":"1990","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0030","first-page":"71","article-title":"Evaluation of antibacterial activities of flomoxef against ESBL producing Enterobacteriaceae analyzed by Monte Carlo simulation","volume":"66","author":"Ito","year":"2013","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0035","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/AAC.34.5.858","article-title":"Activities of \u03b2-lactam antibiotics against Escherichia coli strains producing extended spectrum b-lactamases","volume":"34","author":"Jacoby","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0040","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1128\/AAC.37.5.957","article-title":"In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria","volume":"37","author":"Kato","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4014\/jmb.1306.06036","article-title":"Characterization of CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from urine specimens in a tertiary-care hospital","volume":"24","author":"Kim","year":"2014","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0050","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/jac\/dkl381","article-title":"Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates","volume":"58","author":"Lee","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0055","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jac\/dkm215","article-title":"Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases","volume":"60","author":"Lee","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0060","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/AAC.02155-12","article-title":"Genetic characterization of IncI2 plasmids carrying blaCTX-M-55 spreading in both pets and food animals in China","volume":"57","author":"Lv","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0065","first-page":"494","volume":"28","author":"MHW Pharmaceutical Affairs Bureau","year":"1997"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0070","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.40.6.2153-2162.2002","article-title":"Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR","volume":"40","author":"P\u00e9rez-P\u00e9rez","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0075","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.vetmic.2014.06.013","article-title":"Increasing prevalence of extended-spectrum cephalosporin-resistant Escherichia coli in food animals and the diversity of CTX-M genotypes during 2003\u20132012","volume":"172","author":"Rao","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0080","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1128\/AAC.47.2.790-793.2003","article-title":"Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China","volume":"47","author":"Wang","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0085","doi-asserted-by":"crossref","first-page":"e100707","DOI":"10.1371\/journal.pone.0100707","article-title":"Dominance of CTX-M-type extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China","volume":"9","author":"Xia","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0095","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijantimicag.2010.09.001","article-title":"Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China: the 2002-2009 Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"36","author":"Yang","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0090","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1099\/jmm.0.059816-0","article-title":"A 10year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China","volume":"62","author":"Yang","year":"2013","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1099\/jmm.0.006007-0","article-title":"Characterization of two plasmid-encoded cefotaximases found in clinical Escherichia coli isolates: CTX-M-65 and a novel enzyme, CTX-M-87","volume":"58","author":"Yin","year":"2009","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijantimicag.2011.12.001","article-title":"Prevalence and characterisation of CTX-M \u03b2-lactamases amongst Escherichia coli isolates from healthy food animals in China","volume":"39","author":"Zheng","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2015.01.001_bb0110","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/AAC.00107-08","article-title":"Dominance of blaCTX-M within an Australian extended-spectrum beta-lactamase gene pool","volume":"52","author":"Zong","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889315000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889315000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T11:57:27Z","timestamp":1537963047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889315000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0732889315000024"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.01.001","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flomoxef showed excellent in vitro activity against clinically important gram-positive and gram-negative pathogens causing community- and hospital-associated infections","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}